glp-1 obesity drug news today oct 23 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ ADA '26: Lilly's dominance, Pfizer's
Description
With incretin-based drugs, much of the reported lean mass loss may not be skeletal muscle, but some is
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
Requires medical evaluation and approval by a licensed provider
CivicScience offers insights into the impact of cost, side effects & trends in GLP-1 usage.
Learn about eligibility, deadlines, and how to file a claim.
Lawsuits over severe side effects from taking GLP-1 medications Ozempic, Wegovy, Mounjaro, Trulicity, and Rybelsus
